UNC Lineberger Comprehensive Cancer Center: Urinary Bladder Neoplasms trials

The registry lists 14 Urinary Bladder Neoplasms studies with UNC Lineberger Comprehensive Cancer Center as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 2 3No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and SurvivalRecruitingNCT06896162Not applicable
• Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS)CompletedNCT04492007Not applicableResults posted
• Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder CancerActive, not recruitingNCT03978624Phase 2Results posted
• Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant TherapyCompletedNCT02690558Phase 2Results posted
• Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder CancerCompletedNCT00380029Phase 2Results posted
• Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer SurvivorsCompletedNCT06171945Not applicable
• Physical Therapy in Pre-cystectomy PatientsCompletedNCT05978570
• ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality TherapyCompletedNCT05630131
• Early Intervention for Impairments Identified During Comprehensive Geriatric Assessment in Patients With Bladder CancerTerminatedNCT04273724Not applicable
• Testing the Utilization of a Mobile Health App for Patients Undergoing Cystectomy Surgery for Bladder CancerCompletedNCT03862105Not applicable
• Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer PatientsCompletedNCT03156244
• Single Subject Neratinib in Bladder Cancer (NRR)No longer availableNCT01956253
• Study of Outcomes After Surgery/Treatment to Treat Bladder CancerCompletedNCT01776138
• Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder CancerCompletedNCT01655745Not applicable